Galderma today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion and recommended granting the marketing ...

Jojoba is a seed oil made from a desert shrub. It’s used to restore hair to its optimal state. Learn how to apply jojoba oil ...

If a child’s skin condition persists or worsens despite home care, consult a dermatologist or pediatrician. Signs to watch ...

Brittany Lancellotti, DVM, DACVD, offered ways veterinarians can help reduce caregiver burden in clients in an interview at the 2024 Fetch Long Beach conference ...

A promising new approach to taming troublesome skin conditions could be on the horizon thanks to an examination of skin cells.

As previously reported, Guggenheim downgraded Q32 Bio (QTTB) to Neutral from Buy and removed the firm’s prior price target following the ...

AnaptysBio has reported that the ARISE-AD trial of its investigational B and T lymphocyte attenuator (BTLA) agonist, ANB032, ...

People who live in areas with higher levels of fine particle air pollution face about twice the risk of developing atopic ...

AnaptysBio discontinues ANB032 for atopic dermatitis after a trial failure, refocusing on autoimmune assets with upcoming ...

Q32 Bio reports Phase 2a SIGNAL-AA trial results for bempikibart in alopecia areata, showing safety and modest efficacy.

Dupilumab treatment improves signs and symptoms of atopic dermatitis (AD) in young children, according to a study p ...